# Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary Disease

> **NCT01465906** · PHASE4 · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** tulobuterol
- **DRUG:** Tiotropium Bromide
- **DRUG:** tiotropium bromide

## Key facts

- **NCT ID:** NCT01465906
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-11
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2011-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01465906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01465906, "Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01465906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*